Genea Biocells Expands Operations Center In San Diego, California
Genea Biocells' new premises include office and laboratory space to accommodate the company's cell and culture media manufacturing, research services and R&D. According to the firm, the move represents a substantial investment in California with the new site housing over $2 million worth of equipment, including sophisticated robotics and instrumentation for screening.
The site is expected to be fully operational from September 2015 and by early 2016 will house up to 15 scientists. "This is an exciting strategic move and the next step to grow Genea Biocells into a world leading stem cell company. The new facility not only places us directly into our main market, the USA, but also in the midst of one of the largest biotechnology clusters in the world," Genea Biocells General Manager Dr. Uli Schmidt said.
"Being in California also offers a new range of funding opportunities that we will explore to support our R&D programs on neuromuscular diseases,” he added.
Supply Chain Bottlenecks Creating New “Logistical Hotspots”
2020 Top States for Doing Business Showcase Their Pro-Business Environments
2021 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
35th Annual Corporate Survey: Effects of Global Pandemic Reflected in Executives’ Site and Facility Plans
Latest Trends in the Industrial Real Estate Sector Here to Stay
Auto Industry Is Betting on Sustainability
2021 Auto/Aero Site Guide